Latest filing published 24 Sept 2026 for OncoZenge AB, €26k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Per Daniel Ehrenstråhle: trading record in brief
Filings by Per Daniel Ehrenstråhle span 2 companies, the busiest being OncoZenge AB and Borkenholm. Over a trading history stretching from 1 November 2023 to 23 September 2026, the count stands at 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €37k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 24 September 2026: an open-market purchase of €26k, in OncoZenge AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Per Daniel Ehrenstråhle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ SEK 3.0058.7% of flowBTA (betald tecknad aktie)ISIN SE0030264628FI:csv-4794123c9b967d25fee3Canonical exit: 22 Dec 2026 (T+90)
- 1,000,000 shares@ SEK 0.20741.3% of flowTeckningsoptionFI:csv-2661306bb9c361952e04
- 350,000 shares@ SEK 0.368100.0% of flowTeckningsoptionFI:csv-d31a0c13925909d0a47cCanonical exit: 30 Jan 2024 (T+90)
3 of 3 declarations